For U.S. Residents Only

Checking in with your doctor

patients-img

Watch for the return of any aTTP/iTTP* symptoms. If you think that you have any symptoms of an aTTP/iTTP episode, visit your local emergency room right away

*aTTP is also known as iTTP. The terms can be used interchangeably.

Tell your doctor if:

  • You bleed excessively during treatment. Your doctor may ask you to stop treatment, and they will decide when you can start your treatment again
  • You are using blood thinners (heparin, warfarin, rivaroxaban, apixaban, etc.)
  • You have a bleeding disorder such as hemophilia. Your doctor will decide how you should be treated
  • You have history of liver issues
  • You are going to have an operation or dental treatment. Your doctor may advise you to postpone or stop CABLIVI before your surgery or dental work

Sample questions for your doctor

  • 1. How will I know that CABLIVI is working?
  • 2. How long will I need to take CABLIVI?
  • 3. Will I continue to have symptoms of aTTP/iTTP after I take CABLIVI?
  • 4. Is there anything I can do to prevent another aTTP/iTTP episode?

For a full list of questions, download the CABLIVI Doctor Discussion Guide.

pdf-view
CABLIVI Doctor Discussion Guide

Suggested questions to ask your doctor about treatment with CABLIVI.

Alex, real patient. Individual results may vary.
Alex is being compensated by Sanofi.

Every aTTP/iTTP experience is different

See the signs and symptoms

Download, save, and print

Explore helpful resources
IMPORTANT SAFETY INFORMATION AND INDICATIONS
Who should not take CABLIVI?

Do not take CABLIVI if you've had an allergic reaction to caplacizumab-yhdp or to any of the ingredients in CABLIVI.

What should I tell my healthcare team before starting CABLIVI?
Add
IMPORTANT SAFETY INFORMATION AND INDICATIONS
What is CABLIVI?

CABLIVI (caplacizumab-yhdp) is a prescription medicine used for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.

Who should not take CABLIVI?

Do not take CABLIVI if you've had an allergic reaction to caplacizumab-yhdp or to any of the ingredients in CABLIVI.

What should I tell my healthcare team before starting CABLIVI?

Tell your doctor if you have a medical condition including if you have a bleeding disorder. Tell your doctor about any medicines you take, including medicines that increase your risk of bleeding such as anti-coagulants and anti-platelet agents.

Talk to your doctor before scheduling any surgery, medical or dental procedure.

What are the possible side effects of CABLIVI?

CABLIVI can cause severe bleeding. In clinical studies, severe bleeding adverse reactions of nosebleed, bleeding from the gums, bleeding in the stomach or intestines, and bleeding from the uterus were each reported in 1% of subjects. In the post-marketing setting, cases of life-threatening and fatal bleeding were reported in patients receiving CABLIVI. Contact your doctor immediately if symptoms of excessive bruising, excessive bleeding, or major bleeding occur. Signs and symptoms of bleeding include: pain, swelling or discomfort, prolonged bleeding from cuts, increased menstrual flow or vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or dark brown urine, red or tar black stools, headache, dizziness, or weakness.

You may have a higher risk of bleeding if you have a bleeding disorder (i.e. hemophilia) or if you take other medicines that increase your risk of bleeding such as anti-coagulants and anti-platelet agents.

CABLIVI should be stopped for 7 days before surgery or any medical or dental procedure. Talk to your doctor before you stop taking CABLIVI.

The most common side effects include nosebleed, headache and bleeding gums.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of CABLIVI. Call your doctor for medical advice about side effects.

Please see full Prescribing Information
Instructions for Use
Sharps Medical Waste Disposal (PDF)

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.

aTTP=acquired thrombotic thrombocytopenic purpura; iTTP=immune-mediated thrombotic thrombocytopenic purpura; TTP=thrombotic thrombocytopenic purpura.